Thus, such known features of cancer cells as increased glutathione and the up-regulated thiol-disulfide reductases thioredoxin and glutaredoxin, may promote the ROS production by OGDHC, requiring decreased levels of holo-OGDHC in cancer vs normal cells (Table 2). Here, GLRX is linked to cancer.